|
SLC10A7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
7.01660951563099E-14 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
7.484600E-01 |
| Stage1-vs-Stage3 |
2.452000E-02 |
| Stage1-vs-Stage4 |
2.104200E-02 |
| Stage2-vs-Stage3 |
2.355400E-01 |
| Stage2-vs-Stage4 |
1.155020E-01 |
| Stage3-vs-Stage4 |
6.216200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.25709997966794E-09 |
| Normal-vs-Asian |
1.62547753035369E-12 |
| Caucasian-vs-AfricanAmerican |
4.938400E-01 |
| Caucasian-vs-Asian |
8.590800E-01 |
| AfricanAmerican-vs-Asian |
6.315800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
9.166800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
4.15390000000349E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.826200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.610800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.426200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.887400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.925600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.313800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.04050000004907E-06 |
| Classical-VS-Follicular |
1.717390E-01 |
| Classical-VS-Other |
2.850200E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
9.22250000034985E-07 |
| Tall-VS-Other |
3.110400E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.939960E-01 |
| Follicular-VS-Normal |
2.02959871131725E-12 |
| Other-VS-Normal |
1.4762000000168E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.580830E-01 |
|
|
